Dr Sally Spencer

Associate Director of Clinical Research

Publications

O'Connell NE, Wand BM, Marston L, Spencer S, DeSouza LH. Non-invasive brain stimulation techniques for chronic pain in adults. A report of a Cochrane systematic review and meta-analysis. Eur J Phys Rehabil Med 2011. 47:1-18

O'Connell NE, Wand BM, Marston L, Spencer S, DeSouza LH. Non-invasive brain stimulation techniques for chronic pain in adults. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD008208. DOI: 10.1002/14651858.CD008208

Spencer S. Health status measurement in stable and exacerbated COPD. Expert Review of Respiratory Medicine 2009. 3 (6):573-583

Spencer S, Evans D. Inhaled corticosteroids versus long acting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD007033. DOI: 10.1002/14651858.CD007033

Spencer S. Preparation for Professional Practice: Evidence-Based Practice In Atwal A & Jones M (Eds) Preparing for Professional Practice in Health and Social Care, (2008) Wiley-Blackwell, Oxford. ISBN 978-1-4051-7593-7

Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specific version of the St George's Respiratory Questionnaire. Chest 2007. 132:456-63

Spencer S, Mayer B, Bendall KL, Bateman ED. Validation of a guideline-based composite outcome assessment tool for asthma control. BMC Respiratory Research 2007. 8:26

Barrett G & Spencer S. Rapid response: Concern about the primary outcome. BMJ http://bmj.bmjjournals.com/cgi/eletters/333/7559/117 2006

Briggs AH, Lozano-Ortega G, Spencer S, Bale G, Spencer MD, Burge PS. Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data. Value in Health 2006. 9 (4): 227-235

Spencer S, Calverley PMA, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. European Respiratory Journal 2004. 23:1-5.

Spencer S and Jones PW. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003. 58:589-593.

Calverley PMA, Spencer S, Willits L, Burge PS, Jones PW. Withdrawal from treatment as an outcome in the ISOLDE study of COPD. Chest 2003. 124:1350-1356.

Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003. 58: 659-664.

Burge PS, Calverley PMA, Jones PW, Spencer S, Anderson JA. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax 2003. 58:654-658.

Spencer S, Calverley PMA, Burge PS, Jones PW, for the ISOLDE group. Health status deterioration in patients with COPD. American Journal of Respiratory and Critical Care Medicine 2001. 163:122-128.

Burge PS, Calverley PMS, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double-blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease; the ISOLDE trial. British Medical Journal 2000. 320:1297-303.